CorMedix (CRMD) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for CorMedix (CRMD) over the last 7 years, with Q3 2025 value amounting to $1.26.
- CorMedix's EPS (Weighted Average and Diluted) rose 262000.0% to $1.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.08, marking a year-over-year increase of 38888.89%. This contributed to the annual value of -$0.3 for FY2024, which is 6653.17% up from last year.
- As of Q3 2025, CorMedix's EPS (Weighted Average and Diluted) stood at $1.26, which was up 262000.0% from $0.28 recorded in Q2 2025.
- In the past 5 years, CorMedix's EPS (Weighted Average and Diluted) registered a high of $1.26 during Q3 2025, and its lowest value of -$0.25 during Q1 2024.
- Its 5-year average for EPS (Weighted Average and Diluted) is $0.06, with a median of -$0.05 in 2024.
- As far as peak fluctuations go, CorMedix's EPS (Weighted Average and Diluted) tumbled by 23095.17% in 2023, and later surged by 262000.0% in 2025.
- CorMedix's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.21 in 2021, then rose by 1.46% to -$0.2 in 2022, then rose by 16.6% to -$0.17 in 2023, then skyrocketed by 234.53% to $0.23 in 2024, then surged by 450.92% to $1.26 in 2025.
- Its EPS (Weighted Average and Diluted) was $1.26 in Q3 2025, compared to $0.28 in Q2 2025 and $0.3 in Q1 2025.